• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 3. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 4. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 5. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

Recent Advances in the Study of 1,3-Difluoro-5-(3-nitrophenyl)benzene (CAS: 865856-72-0) in Chemical Biology and Pharmaceutical Research

The compound 1,3-Difluoro-5-(3-nitrophenyl)benzene (CAS: 865856-72-0) has recently emerged as a molecule of significant interest in chemical biology and pharmaceutical research. This fluorinated aromatic compound, characterized by its unique structural features including two fluorine atoms and a nitro group, has shown promising potential in various applications ranging from medicinal chemistry to materials science. Recent studies have particularly focused on its role as a building block for more complex pharmaceutical agents and its unique physicochemical properties that make it valuable for drug design.

In the context of medicinal chemistry, researchers have explored 1,3-Difluoro-5-(3-nitrophenyl)benzene as a key intermediate in the synthesis of novel kinase inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in constructing selective JAK2 inhibitors, where the fluorine atoms were found to significantly enhance binding affinity through favorable interactions with the kinase's ATP-binding pocket. The nitro group, meanwhile, served as an excellent handle for further chemical modifications, allowing for the rapid generation of diverse analogs for structure-activity relationship studies.

The compound's photophysical properties have also attracted attention in materials science applications. Research published in Advanced Materials in early 2024 revealed that 1,3-Difluoro-5-(3-nitrophenyl)benzene exhibits unusual fluorescence characteristics when incorporated into certain polymer matrices, making it potentially useful for developing new organic light-emitting diodes (OLEDs) with improved efficiency. The presence of both electron-withdrawing (nitro) and electron-donating (fluorine) groups creates an interesting electronic push-pull system that researchers are continuing to explore.

From a synthetic chemistry perspective, recent methodological advances have improved the accessibility of 1,3-Difluoro-5-(3-nitrophenyl)benzene. A 2023 Nature Protocols paper detailed an optimized palladium-catalyzed cross-coupling approach that significantly increases yield while reducing the need for hazardous reagents. This development is particularly important as it addresses previous challenges in scaling up production, which had limited the compound's broader application in pharmaceutical development.

Pharmacokinetic studies of derivatives containing the 1,3-Difluoro-5-(3-nitrophenyl)benzene scaffold have shown interesting metabolic stability profiles. The fluorine atoms appear to confer resistance to oxidative metabolism while the nitro group can be selectively reduced in vivo to yield amino derivatives with altered biological activity. This dynamic behavior is currently being investigated for potential applications in prodrug design, where controlled metabolic activation could improve therapeutic indices.

Looking forward, several research groups have identified 1,3-Difluoro-5-(3-nitrophenyl)benzene as a promising scaffold for fragment-based drug discovery. Its relatively small size combined with multiple points for derivatization make it ideal for this approach. Computational chemistry studies predict that further optimization of this core structure could lead to compounds with activity against challenging targets such as protein-protein interactions, which have traditionally been difficult to address with small molecules.

In conclusion, the growing body of research on 1,3-Difluoro-5-(3-nitrophenyl)benzene (CAS: 865856-72-0) highlights its versatility and potential across multiple areas of chemical and pharmaceutical research. As synthetic methods continue to improve and our understanding of its unique properties deepens, this compound is likely to play an increasingly important role in the development of new therapeutic agents and functional materials.

• 499-08-1(3-Fluoro-5-nitrotoluene)
• 731845-39-9((4'-Fluoro-3-nitrobiphenyl-4-yl)amine)
• 72093-49-3(1-Fluoro-3-(4-nitrophenyl)benzene)
• 1352318-59-2(2-fluoro-1-methyl-4-(4-nitrophenyl)benzene)
• 398-24-3(1,1'-Biphenyl,4-fluoro-4'-nitro-)
• 179897-91-7([1,1'-Biphenyl]-4-amine, 3-fluoro-3'-nitro-)
• 910301-32-5(1,3-Difluoro-5-(4-nitrophenyl)benzene)
• 10540-32-6(1-Fluoro-4-(3-nitrophenyl)benzene)
• 1355247-53-8(2-fluoro-1-methyl-4-(3-nitrophenyl)benzene)
• 1355247-86-7(1-fluoro-2-methyl-4-(3-nitrophenyl)benzene)